| Multidrug-resistant and extensively drug-resistant enterobacteriaceae: prevalence, treatments, and outcomes–a retrospective cohort study H Alkofide, AM Alhammad, A Alruwaili, A Aldemerdash, TA Almangour, ... Infection and Drug Resistance, 4653-4662, 2020 | 78 | 2020 |
| Dalbavancin for the management of gram-positive osteomyelitis: effectiveness and potential utility TA Almangour, GK Perry, CM Terriff, AA Alhifany, KS Kaye Diagnostic Microbiology and Infectious Disease 93 (3), 213-218, 2019 | 71 | 2019 |
| Covid-19 vaccination-related sentiments analysis: a case study using worldwide twitter dataset AA Reshi, F Rustam, W Aljedaani, S Shafi, A Alhossan, Z Alrabiah, ... Healthcare 10 (3), 411, 2022 | 45 | 2022 |
| Multiple weekly dalbavancin dosing for the treatment of native vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case report TA Almangour, V Fletcher, M Alessa, AA Alhifany, D Tabb The American Journal of Case Reports 18, 1315, 2017 | 42 | 2017 |
| Ceftazidime-avibactam versus colistin for the treatment of infections due to carbapenem-resistant Enterobacterales: a multicenter cohort study TA Almangour, L Ghonem, A Aljabri, A Alruwaili, M Al Musawa, N Damfu, ... Infection and drug resistance, 211-221, 2022 | 39 | 2022 |
| Dalbavancin for the management of osteomyelitis: a major step forward? TA Almangour, AA Alhifany Journal of Antimicrobial Chemotherapy 75 (10), 2717-2722, 2020 | 24 | 2020 |
| Ceftolozane-Tazobactam versus ceftazidime-avibactam for the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa: a multicenter cohort study TA Almangour, L Ghonem, D Alassiri, A Aljurbua, M Al Musawa, A Alharbi, ... Antimicrobial Agents and Chemotherapy 67 (8), e00405-23, 2023 | 22 | 2023 |
| Efficacy and safety of eravacycline: A meta-analysis K Eljaaly, JK Ortwine, M Shaikhomer, TA Almangour, M Bassetti Journal of Global Antimicrobial Resistance 24, 424-428, 2021 | 22 | 2021 |
| Work readiness scale for pharmacy interns and graduates: A cross-sectional study SSA Abuhussain, ME Elrggal, AK Salamatullah, AA Althobaity, AF Alotaibi, ... Saudi Pharmaceutical Journal 29 (9), 976-980, 2021 | 21 | 2021 |
| Evaluating the effect of antibiotics sub-inhibitory dose on Pseudomonas aeruginosa quorum sensing dependent virulence and its phenotypes FS Aleanizy, FY Alqahtani, EK Eltayb, N Alrumikan, R Almebki, ... Saudi Journal of Biological Sciences 28 (1), 550-559, 2021 | 21 | 2021 |
| Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study TA Almangour, A Aljabri, M Al Musawa, A Almohaizeie, S Almuhisen, ... Journal of Global Antimicrobial Resistance 28, 288-294, 2022 | 20 | 2022 |
| Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: a retrospective matched cohort study TA Almangour, GK Perry, AA Alhifany Saudi Pharmaceutical Journal 28 (4), 460-464, 2020 | 20 | 2020 |
| Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective … TA Almangour, A Alruwaili, R Almutairi, A Alrasheed, AA Alhifany, ... International Journal of Infectious Diseases 108, 406-412, 2021 | 17 | 2021 |
| Association between graduates' factors and success rate on the Saudi Pharmacist Licensure Examination: A single-Institution cross-sectional study AA Alhifany, FA Almalki, YM Alatawi, LA Basindowh, SS Almajnoni, ... Saudi Pharmaceutical Journal 28 (12), 1830-1833, 2020 | 16 | 2020 |
| Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review … AA Alhifany, AR Almutairi, TA Almangour, AN Shahbar, I Abraham, ... BMJ open 9 (11), e031145, 2019 | 16 | 2019 |
| Effectiveness and safety of ceftriaxone compared to standard of care for treatment of bloodstream infections due to methicillin-susceptible Staphylococcus aureus: a systematic … YS Alsowaida, G Benitez, K Bin Saleh, TA Almangour, F Shehadeh, ... Antibiotics 11 (3), 375, 2022 | 15 | 2022 |
| Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes TA Almangour, E Garcia, Q Zhou, A Forrest, KS Kaye, J Li, T Velkov, ... International journal of antimicrobial agents 57 (6), 106328, 2021 | 14 | 2021 |
| Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia TA Almangour, B Alenazi, L Ghonem, AA Alhifany, BA Aldakheel, ... Saudi Pharmaceutical Journal 28 (8), 1009-1013, 2020 | 14 | 2020 |
| Ceftolozane–tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a patient receiving intermittent hemodialysis MA Alessa, TA Almangour, A Alhossan, MA Alkholief, M Alhokail, ... The Bulletin of the American Society of Hospital Pharmacists 75 (9), e184-e188, 2018 | 14 | 2018 |
| Antimicrobial resistance awareness, antibiotics prescription errors and dispensing patterns by community pharmacists in Saudi Arabia AM Alajmi, AA Alamoudi, AA Halwani, TA Almangour, NH Almozain, ... Journal of Infection and Public Health 16 (1), 34-41, 2023 | 11 | 2023 |
